Daily News and Research on Pharmaceuticals Stocks (10/1/2008)
Below is today's Daily News and Research on Pharmaceutical Stocks. Click here for historical daily updates.
ABT: STOCK PICKS: Top Five Large-Cap Stocks for Oct. 1 - at TheStreet.com (Wed 7:00am)
ABT WYE: UPDATE - Advanced Life, Wyeth unit in pact for pneumonia drug - at Reuters (Wed 8:01am)
AFFX: Affymetrix and Medical Prognosis Institute Collaborate to Develop Cancer Treatment Products - Business Wire (Wed 8:00am)
AMGN: Fast Money' Recap: Snapping Back - at TheStreet.com (Tue 7:16pm)
AMGN: Volatile 3rd quarter for stocks ends on up note - AP (Tue 7:04pm)
AMGN: Amgen Receives Executive Summary from Independent Cochrane Collaboration Review of ESAs in Oncology - Business Wire (Tue 7:02pm)
BIIB: Your First Move For Wednesday October 1st - at CNBC (Tue 7:13pm)
BMY: Thirteen Advocacy Groups Collaborate on New Online Resource Dedicated to Patients with Advanced Breast Cancer - Business Wire (Wed 9:00am)
CEPH: The Technical Indicator: Three ways to play defense in October - at MarketWatch (Wed 12:01am)
HGSI: Iconix Brand Group, Salix Pharmaceuticals and Human Genome Sciences most actively traded companies - SmallCapInvestor.com (Wed 9:05am)
IMCL: Market Chatter -- Corporate finance press digest - at Reuters (Wed 2:49am)
JNJ: Boston Sci to pay J&J over $700 million in patent case - at MarketWatch (Wed 8:56am)
DAILY NEWS & RESEARCH ON HEALTH CARE STOCKS - Click here
JNJ: Ahead of the Bell: J&J wins stent patent dispute - AP (Wed 8:50am)
JNJ: Boston Scientific Announces Court Decision - PR Newswire (Wed 8:30am)
JNJ: Bayer wins European approval for Xarelto pill - at Reuters (Wed 5:32am)
JNJ: Mark Hulbert: What the election means for the stock market - at MarketWatch (Wed 12:01am)
JNJ: Boston Scientific ordered to pay $703 million in stent case - at bizjournals.com (Tue 8:15pm)
JNJ: J&J: Court rules rivals pay $1.2B in patent fight - AP (Tue 6:52pm)
JNJ: Cordis wins $1.22 billion judgment in patent cases - at MarketWatch (Tue 6:43pm)
LLY: Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimer's Disease Compound - PR Newswire (Wed 8:00am)
MRK PFE: Big Pharma 'could free up $35 bln working capital' - at Reuters (Wed 9:28am)
PFE: Shareholder Rights in the Corporate Boardroom - at BusinessWeek (Wed 8:08am)
PFE: Business Highlights - AP (Tue 6:41pm)
WYE: Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region - PR Newswire (Wed 6:31am)
WYE: Danish study finds HRT does not raise heart attack - at Reuters (Tue 7:01pm)
Comments